Related Experiment Video
Updated: Apr 17, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
[Therapeutic monitoring of amikacin and gentamicin in routine clinical practice]
Abstract:
Aminoglycosides constitute one of the oldest classes of antimicrobials. Despite their relative toxicity, mainly nephrotoxicity and ototoxicity, aminoglycosides are valuable in current clinical practice. They are bactericidal agents with activity against aerobic gram-negative infections and against gram-positive cocci when added to a cell wall active antimicrobial-based regimen (e.g. betalactams). Aminoglycosides have a concentration-dependent bactericidal effect and a long post antibiotic effect. There is accumulating evidence to show that large, single, daily doses (or more correctly, extended interval dosing) of aminoglycosides is associated with less nephrotoxicity and ototoxicity and comparable, if not superior clinical outcomes than the same total dose administered in small, multiple doses. The efficacy and toxicity of aminoglycosides show a strong direct positive relationship with blood drug concentrations. A key strategy in minimizing toxicity and optimizing therapy is therapeutic drug monitoring. Key words: aminoglycosides - amikacin - gentamicin - therapeutic monitoring.
Insights
Aminoglycosides are effective antimicrobials, but can be toxic. Extended interval dosing reduces toxicity and improves outcomes, with therapeutic drug monitoring optimizing their use.
Area of Science:
- Pharmacology
- Infectious Diseases
- Clinical Pharmacy
Background:
- Aminoglycosides are essential antimicrobials for aerobic gram-negative infections and synergistic gram-positive therapy.
- Despite known nephrotoxicity and ototoxicity, their clinical value persists.
- These agents exhibit concentration-dependent bactericidal effects and a notable post-antibiotic effect.
Purpose of the Study:
- To review the efficacy and toxicity of aminoglycosides.
- To highlight the benefits of extended interval dosing.
- To emphasize the role of therapeutic drug monitoring in optimizing aminoglycoside therapy.
Main Methods:
- Literature review of aminoglycoside pharmacology, clinical use, and toxicity.
- Analysis of evidence supporting extended interval dosing strategies.
- Discussion of therapeutic drug monitoring principles for aminoglycosides.
Main Results:
- Extended interval dosing of aminoglycosides is associated with reduced nephrotoxicity and ototoxicity.
- Clinical outcomes with extended interval dosing are comparable or superior to traditional multiple daily dosing.
- Aminoglycoside efficacy and toxicity are directly related to blood drug concentrations.
Conclusions:
- Extended interval dosing represents an optimized strategy for aminoglycoside administration.
- Therapeutic drug monitoring is crucial for minimizing aminoglycoside toxicity and maximizing efficacy.
- Aminoglycosides remain valuable agents when administered and monitored appropriately.
More Related Videos
Related Concept Videos
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Estimation of k and VD of Aminoglycosides
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring: Drug Analysis Methods

